MurrayJF, MatthayMA, LuceJM, FlickMR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis., 1988; 138(3):720–723.
3.
BernardGR, ArtigasA, BrighamKL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med., 1994; 149(3 Pt 1):818–824.
4.
BrowerRG, MatthayMA, MorrisA, SchoenfeldD, ThompsonBT, WheelerA; Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med., 2000; 342(18):1301–1308.
5.
RanieriVM, RubenfeldGD, ThompsonBT, et al; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA., 2012; 307(23):2526–2533.
6.
RivielloED, KiviriW, TwagirumugabeT, et al. Hospital incidence and outcomes of the acute respiratory distress syndrome using the Kigali modification of the Berlin definition. Am J Respir Crit Care Med., 2016; 193(1):52–59.
7.
WareLB. Go with the flow: expanding the definition of ARDS to include high-flow nasal oxygen. Am J Respir Crit Care Med., 2022.
8.
MatthayMA, ThompsonBT, WareLB. The Berlin definition of acute respiratory distress syndrome: should patients receiving high-flow nasal oxygen be included?. Lancet Respir Med., 2021; 9(8):933–936.
9.
van der VenF-S, ValkCMA, BlokS, et al; PRoAcT–COVID study investigators. Broadening the Berlin definition of ARDS to patients receiving high-flow nasal oxygen: an observational study in patients with acute hypoxemic respiratory failure due to COVID-19. Ann Intensive Care., 2023; 13(1):64.
10.
MatthayMA, ArabiY, ArroligaAC, et al. A new global definition of acute respiratory distress syndrome. Am J Respir Crit Care Med., 2024; 209(1):37–47.
11.
IshaS, OlaizolaGJ, Carboni BissoI, et al. Evaluating the newly proposed ARDS definition in hospitalized COVID-19 patients treated with high-flow nasal oxygen: a retrospective cohort study. Respir Care., 2025; 70(2):119–125.
12.
MatthayMA, McAuleyDF, WareLB. Clinical trials in acute respiratory distress syndrome: challenges and opportunities. Lancet Respir Med., 2017; 5(6):524–534.
13.
CalfeeCS, DelucchiK, ParsonsPE, ThompsonBT, WareLB, MatthayMA; NHLBI ARDS Network. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomized controlled trials. Lancet Respir Med., 2014; 2(8):611–620.
14.
BeitlerJR, ThompsonBT, BaronRM, et al. Advancing precision medicine for acute respiratory distress syndrome. Lancet Respir Med., 2022; 10(1):107–120.
15.
WareLB, MatthayMA, MebazaaA. Designing an ARDS trial for 2020 and beyond: focus on enrichment strategies. Intensive Care Med., 2020; 46(12):2153–2156.
16.
AlemayehuC, MitchellG, NiklesJ. Barriers for conducting clinical trials in developing countries- a systematic review. Int J Equity Health., 2018; 17(1):37.
